Toolkit for emerging technologies in laboratory medicine

Author:

Greaves Ronda12ORCID,Kricka Larry3,Gruson Damien4,Ferrari Maurizio5,Martin Helen6,Loh Tze Ping7,Bernardini Sergio8

Affiliation:

1. Victorian Clinical Genetics Services , Murdoch Children’s Research Institute , Parkville , VIC , Australia

2. Department of Paediatrics , University of Melbourne , Melbourne , VIC , Australia

3. Department of Pathology and Laboratory Medicine , University of Pennsylvania Medical Center , Philadelphia , PA , USA

4. Cliniques Universitaires Saint Luc, Département des Laboratoires Cliniques , Biochimie Médicale , Brussels , Belgium

5. IRCCS Synlab SDN Naples , Naples , Italy

6. SA Pathology , Adelaide , SA , Australia

7. National University Hospital , Singapore , Singapore

8. Department of Experimental Medicine , University Tor Vergata , Rome , Italy

Abstract

Abstract An emerging technology (ET) for laboratory medicine can be defined as an analytical method (including biomarkers) or device (software, applications, and algorithms) that by its stage of development, translation into broad routine clinical practice, or geographical adoption and implementation has the potential to add value to clinical diagnostics. Considering the laboratory medicine-specific definition, this document examines eight key tools, encompassing clinical, analytical, operational, and financial aspects, used throughout the life cycle of ET implementation. The tools provide a systematic approach starting with identifying the unmet need or identifying opportunities for improvement (Tool 1), forecasting (Tool 2), technology readiness assessment (Tool 3), health technology assessment (Tool 4), organizational impact map (Tool 5), change management (Tool 6), total pathway to method evaluation checklist (Tool 7), and green procurement (Tool 8). Whilst there are differences in clinical priorities between different settings, the use of this set of tools will help support the overall quality and sustainability of the emerging technology implementation.

Publisher

Walter de Gruyter GmbH

Subject

Biochemistry (medical),Clinical Biochemistry,General Medicine

Reference83 articles.

1. Coronavirus (COVID-19) update: FDA authorizes first COVID-19 test for self-testing at home [press release]. U.S. Food and Drug Administration; 17th Nov 2020. Available from: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-covid-19-test-self-testing-home.

2. Coronavirus (COVID-19) update: FDA authorizes antigen test as first over-the-counter fully at-home diagnostic test for COVID-19 [press release]. FDA; December 15, 2020. Available from: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-antigen-test-first-over-counter-fully-home-diagnostic.

3. FDA. In vitro diagnostics EUAs – antigen diagnostic tests for SARS-CoV-2 U.S. food and drug administration; 2023. Available from: https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-antigen-diagnostic-tests-sars-cov-2.

4. FDA. In vitro diagnostics EUAs – molecular diagnostic tests for SARS-CoV-2: U.S. food and drug administration; 2023. Available from: https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-molecular-diagnostic-tests-sars-cov-2.

5. FDA. In vitro diagnostics EUAs – serology and other adaptive immune response tests for SARS-CoV-2: U.S. Food and drug administration; 2023. Available from: https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-serology-and-other-adaptive-immune-response-tests-sars-cov-2.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3